Journal of Drugs in Dermatology

View more issues:

Articles in Sept-Oct, 2005 issue of Journal of Drugs in Dermatology

• T4N5 liposomal lotion in preventing the recurrence of nonmelanoma skin cancer in patients who have undergone a kidney transplant
• Safety study of S-Caine Peel before a painful dermatologic procedure in adults
• Hydroxychloroquine vs. clobetasol rinse to treat oral lichen planus
• FDA approves Enbrel for psoriatic arthritis
• Celecoxib in preventing skin cancer
• Phase II randomized bilateral comparison of topical targretin gel 1% in alopecia areata
• Evaluation of a flexible new liquid polymer wound dressing
  by Sherry H. Hsiung
• Montelukast treatment of moderate to severe atopic dermatitis in adults: a randomized, double-blind, placebo-controlled trial
• FDA approves Tygacil for the treatment of complicated skin and skin structure infections
• Study of talabostat and cisplatin in advanced melanoma
• A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis
• Biologic therapy for psoriasis: an update on the tumor necrosis factor inhibitors infliximab, etanercept, and adalimumab, and the T-Cell-targeted therapies efalizumab and alefacept
  by Jeffrey M. Weinberg
• Cutaneous leiomyomatosis and parotid pleomorphic adenoma
  by Jorge Ocampo-Candiani
• Photodynamic therapy in treating patients with skin cancer
• Mechanisms of skin repair by topical estrogen
• Oral acyclovir for neonatal HSV disease of the skin, eyes and mouth
• Inpatient management of severe psoriasis
  by Andrew A. Nelson
• Reticulate hyperpigmentation secondary to 5-fluorouracil and idarubicin
  by Reena Jogi
• Nabi Biopharmaceuticals to test staphylococcus epidermidis vaccine
• Treatment of cholestatic pruritus with sertraline
• The Face and Mind Evaluation study: an examination of the efficacy of rosacea treatment using physician ratings and patients' self-reported quality of life
  by Alan Fleischer
• Linezolid in the treatment of complicated skin and soft tissue due to methicillin-resistant staphylococcus aureus
• The role of number of treatments in laser-assisted hair removal using a 755-nm alexandrite laser
  by Navid Bouzari
• Laser and Cosmetic News
  by Macrene Alexiades-Armenakas
• Generic versions of Periostat still available
• Punctate palmoplantar keratoderma with psoriasis: a rare association showing excellent response to acitretin
  by Nawaf Al-Mutairi
• Infliximab to treat dermatomyositis and polymyositis
• A letter from the guest editor
  by Sherry H. Hsiung
• Effective treatment of female androgenic alopecia with dutasteride
  by Malgorzata Olszewska
• Photodynamic therapy in treating patients with skin cancer or solid tumors metastatic to the skin
• FDA approves infliximab for psoriatic arthritis
• ZD1839 for recurrent or metastatic squamous cell carcinoma of the skin
• A multi-center study of short and long-term use of Protopic Ointment in patients with atopic dermatitis
• Etanercept in Psoriasis pediatrics
• Terbinafine compared to griseofulvin in children with tinea capitis
• Merrem approved for skin infections
• Bevacizumab to treat Kaposi's sarcoma in HIV-positive and HIV-negative patients
• Assessment of skin barrier function in rosacea patients with a novel 1% metronidazole gel
  by Zoe D. Draelos
• Pancytopenia after a single intradermal infiltration of methotrexate
  by Philip R. Cohen
• Topical imiquimod compared with surgery in treating patients with basal cell skin cancer
• A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination cream in melasma patients previously treated with TC cream or one of its dyads
  by Helen Torok
• Etanercept for treatment of hidradenitis
• Immunotherapy today: the story of a vaccine
  by Donald L. Morton
• Corgentech to test NF-[kappa]B decoy for the treatment of eczema
• Successful treatment of Mycobacterium marinum infection with minocycline after complication of disease by delayed diagnosis and systemic steroids
  by Joseph P. Janik
• Zostavax study shows promising results
• Photodynamic therapy using silicon phthalocyanine 4 in treating patients with AK, Bowen's disease, skin cancer, or stage I or stage II mycosis fungoides
• Utilization of narrow band ultraviolet B light therapy and etanercept for the treatment of psoriasis
• Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial
• Oracea reduces lesion count in rosacea patients
• Imiquimod and superficial skin cancers
  by Mark Naylor
• Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens
• Connetics receives FDA non-approvable letter for Velac
• Open-label safety study to evaluate imiquimod cream 5% for large areas of AK
• ADEPT Study demonstrates that Humira improves quality of life for paatients with psoriatic arthritis
• Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study
  by Steven Bowman
• Psoraxine
• Bioengineered skin and wound healing
• Study of the use of humanized CD25 in preventing the relapse of psoriasis vulgaris
• Comparison of telavancin and vancomycin for complicated skin and skin structure infections with a focus on methicillin-resistant staphylococcus aureus